1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Eli Lilly and Company

Eli Lilly and Company

LLY
Eli Lilly and CompanyUS flagNew York Stock Exchange
1,188.57
USD
-28.38
- -
1.12TMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
20.7
17.66
18.06
19.28
18.99
20.91
23.31
25.65
29.69
30.04
37.94
50.19
72.84
80.68
Basic EPS, GAAP
4.19
2.15
2.18
2.49
-0.19
3.14
8.69
6.47
5.85
6.57
5.83
11.8
23.07
28.23
Free Cash Flow per Basic Share
4.16
2.6
1.21
3.41
3.28
2.44
3.64
4.67
5.65
4.84
-3.5
0.46
6.67
11.58
Dividend per Share
1.9
1.89
1.92
1.96
2.08
2.25
2.52
2.81
3.24
3.72
4.52
5.21
6.02
6.24
Book Value per Share
15.84
15.47
15.11
15.2
13.86
11.73
5.76
8.81
10.02
11.19
12.13
15.75
28.01
33.62
Tangible Book Value per Share
11.92
9.68
4.99
5.22
3.11
8.25
-7.94
-5.64
-2.55
-0.53
-1.09
2.6
15.77
19.76
Basic Weighted Avg Shares
1,117
1,111
1,105
1,101
1,052
1,028
958
957
954
950
899
898
895
896
Sales/Revenue/Turnover
23,113
19,616
19,959
21,222
19,974
21,493
22,320
24,540
28,318
28,541
34,124
45,043
65,179
72,250
Operating Margin (%)
24
16.97
18
17.31
20.03
26.92
25.94
28.36
26.99
29.01
30.26
37.83
45.56
47.3
Depreciation Expense
1,446
1,379
1,428
1,497
1,567
1,609
1,233
1,324
1,548
1,522
1,527
1,767
1,997
2,043
Net Income, GAAP
4,685
2,390
2,408
2,738
-204
3,232
8,318
6,194
5,582
6,245
5,240
10,590
20,640
25,277
Effective Tax Rate (%)
20.45
20.32
13.68
18.86
103.75
14.39
11.93
14.33
9.32
8.25
20.05
16.48
19.79
18.79
Profit Margin (%)
20.27
12.19
12.07
12.9
-1.02
15.04
37.27
25.24
19.71
21.88
15.36
23.51
31.67
34.99
Working Capital
4,188
2,187
4,344
4,115
4,666
8,662
1,934
4,980
3,400
896
-1,566
4,364
20,401
18,201
LT Debt
4,200
5,333
7,972
8,368
9,940
9,196
13,818
16,587
15,346
14,738
18,321
28,527
40,868
39,370
Total Equity
17,641
15,388
14,590
14,080
11,668
10,909
2,699
5,825
9,155
10,775
10,864
14,272
26,535
31,198
Return on Invested Capital (%)
19.52
10.88
12.97
12.59
-0.6
20.9
25.67
29.05
28.27
28.34
25.98
33.89
40.74
41.09
Return on Capital (%)
21.27
10.43
10.21
11.15
-0.77
13.3
39.09
28.19
22.73
24.43
17.8
26.74
35.76
40.11
Return on Common Equity (%)
27.16
13.71
14.22
16.37
-1.3
24.27
94.66
88.81
62.08
61.86
48.65
84.57
105.31
110.39

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1,633
1,635
4,000
LT Borrowings
40,874
40,868
39,370
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
896
895
894
Market Capitalization
684,603
963,523
823,663

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
62,071
55,629
54,835
Cash, Cash Equivalents & STI
9,914
7,268
5,282
Accounts Receivable, Net
16,107
17,760
18,429
Inventories
12,180
13,744
14,529
Total Current Liabilities
40,141
35,228
36,634
Payables & Accruals
31,327
22,761
22,576
ST Debt
1,633
1,635
4,000
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.64%
38.59%
85.92%
Free Cash Flow
127.74%
212.97%
1,340.58%
Net Income, GAAP
-146.26%
36.58%
94.9%
Sales/Revenue/Turnover
13.43%
22.49%
44.7%
Total Cash Common Dividend
9.88%
14.91%
15.04%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
8,768
11,303
11,439
13,533
45,043
2025
12,729
15,558
17,601
19,292
65,179
2026
19,799
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.49
3.3
1.08
4.91
11.8
2025
3.07
6.3
6.23
7.42
23.07
2026
8.28
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.3
1.3
1.3
1.3
5.21
2025
1.5
1.5
1.5
1.5
6.02
2026
1.73
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
David A. Ricks
Full Time Employees
47,000
Sector
Healthcare
Industry
Drug Manufacturers - General
Address
Lilly Corporate Center Indianapolis IN United States of America 46285
IPO Date
Jun 1, 1972
CIK
0000059478
Website
lilly.com
Similar Companies
AstraZeneca PLC (AZN)
TTK Healthcare Limited (TTKHLTCARE.NS)
Zoetis Inc. (0M3Q.L)
PT Kalbe Farma Tbk (PTKFY)
Orion Oyj (ORNAV.HE)
Dechra Pharmaceuticals PLC (DPHAY)
Business

Company News

APIChatGPT

  • 247wallst.com

    Eli Lilly's $400 Billion Surge Is Reshaping Big Pharma

  • zacks.com

    Stocks Look Shaky, But This Sector is Booming (Biotech)

  • 247wallst.com

    Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

  • 247wallst.com

    Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

  • zacks.com

    Here's Why Eli Lilly (LLY) is a Strong Growth Stock

  • seekingalpha.com

    Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry

  • fool.com

    Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

  • prnewswire.com

    Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment

  • etftrends.com

    Strong LLY News Boosts Active Healthcare ETF GDOC

  • fool.com

    Is It Too Late to Buy Eli Lilly?

  • marketbeat.com

    The Market Just Got Shaken—These 3 ETFs May Come Out Stronger

  • zacks.com

    LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?

  • 247wallst.com

    This $1,200 Stock Could Be the Next Massive Stock Split Opportunity

  • seekingalpha.com

    Top 50 High-Quality Dividend Growth Stocks For July 2026

  • fool.com

    Why Eli Lilly Stock Climbed to a Record High Today

  • 247wallst.com

    Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They're Dead Wrong

  • fool.com

    U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend

  • investors.com

    Eli Lilly's Market Cap Balloons Again On This IPO's Setback

  • 247wallst.com

    Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

  • fool.com

    Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.